The Week That Was in NorthAsia@Smartkarma: Japan Technical Bulls, Sosei & Jin Air/CTK Cosmetics IPOs
With earnings season coming to a close, content was lighter this week in Japan and Korea. Douglas and Sanghyun provided coverage on the upcoming...
289 Views
Sosei Placement - One-Year Return for Its 2015 Equity Raise Was 354%
Sosei Group Corp (4565 JP) is looking to raise US$204m by selling about 2m primary shares. Proceeds raised will be used to fund drug discovery and...
268 Views
Sosei Offering: Company History, Earnings Structure, Business Model and Use of Proceeds
On 10 Nov 2017 Sosei Group Corp (4565 JP) announced an overseas offering for 2.07m new shares (1.8m + 0.27m overallotment option). The offering...
221 Views
Mitsubishi Tanabe (4508) - Acquisition of NeuroDerm Playing to Strength, Not Weakness
The history of overseas acquisitions by Japanese drug companies is not a pretty one, as they've either overpaid for a skillset (Takeda (4502 JP)...
284 Views
Update on Astellas (4503) As It Gets Orphan Drug Status for Gilteritinib
News that gilteritinib has received orphan drug status for acute myeloid leukaemia (AML) would be rather more exciting for Astellas (4503 JP) but...
255 Views